TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412.

Kara L Davis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.